Ad-Epas1 or empty virus (Ad-C) for 3 hours at the indicated MOI, and cultured in the presence or absence of pharmacological agents. For IA injection of adenovirus, Ad-Nampt, Ad-Epas1, or Ad-C (1  10 9 PFU) was injected into the knee joints of mice once per week for 3 weeks. The mice were co-injected (IA) with the non-competitive NAMPT inhibitor FK866 (10 mg/kg body weight; Cayman) in a total volume of 10 l.
Enzyme-linked immunosorbent assay (ELISA)
Mouse articular chondrocytes were infected with Ad-C (800 MOI) or Ad-Nampt (at the indicated MOI). After 36 hours of culture, the amount of cellular iNAMPT and secreted eNAMPT was determined in whole-cell lysates and culture supernatants, respectively, using a mouse NAMPT ELISA kit (Abnova, KA0095) according to the manufacturer's instructions. Briefly, 100 μl of lysates and purified culture supernatants were added to each well of an ELISA plate at an appropriate dilution. After rigorous washing, samples were incubated with horseradish peroxidase (HRP)-conjugated anti-mouse NAMPT antibody and allowed to undergo a colorimetric reaction with tetra-methylbenzidine (TMB) substrates. Following a 15-minute incubation, the reaction was stopped by the addition of H 2 SO 4 , and absorbance at 450 nm was measured using a VERSAmax microplate reader (Molecular Devices). NAMPT concentrations were estimated by reference to a standard curve generated using serially diluted recombinant mouse NAMPT protein.
Reverse transcription-polymerase chain reaction (RT-PCR), quantitative RT-PCR (qRT-PCR), and small inhibitory RNA (siRNA)
Total RNA was extracted from primary cultured chondrocytes using the TRI reagent (Molecular Research Center Inc.). For cartilage tissues, knee joints of wild-type (WT), transgenic (TG), or knockout (KO) mice were scraped with a blade after DMM surgery or adenovirus injection to remove cartilage, and RNA was isolated using the TRI reagent. The RNA was reverse transcribed, and the resulting cDNA was amplified by PCR. PCR primers and experimental conditions are summarized in online supplementary table S1. Transcript levels were quantified by qRT-PCR. qRT-PCR reactions were performed using an iCycler thermal cycler (Biorad) and SYBR premix Ex Taq (TaKaRa Bio). For each target gene, transcript levels were normalized to those of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and expressed as fold changes relative to the indicated controls. The siRNA sequences that knocked down Epas1 or Nampt most effectively were used in this study (online supplementary table S2 ). Non-targeting (scrambled) siRNA was used as a negative control. Chondrocytes were transfected by incubating for 6 hours with siRNA and Lipofectamine 2000 (Invitrogen), and infected with adenoviruses as described above. Transfection of siRNA (100 nM) did not cause any cytotoxicity in primary cultures of chondrocytes.
Western blotting
Total cell lysates were prepared in lysis buffer (150 mM NaCl, 1% NP-40, 50 mM Tris, 0.2% sodium dodecyl sulfate [SDS], 5 mM NaF) and used to detect iNAMPT. Secreted proteins (eNAMPT, MMP3, MMP12, and MMP13) were detected after trichloroacetic acid (TCA) precipitation from 900 µl of serum-free conditioned medium. All lysis buffers contained a cocktail of protease inhibitors and phosphatase inhibitors (Roche). The following antibodies were used for Western blotting: mouse monoclonal anti-NAMPT (clone OMN1379) from AdipoGen, and mouse monoclonal anti-MMP3 (clone EP1186Y), anti-MMP12 (clone EP1261Y), and anti-MMP13 (clone EP1263Y) from Epitomics.
Cloning, reporter gene assays, promoter binding assays, and chromosome immunoprecipitation (ChIP) assays
The expression vectors for Epas1 and dominant-negative Epas1 (Epas1) have been previously described. 1 Nampt promoter regions were cloned using primers specific for the genomic DNA of C57BL/6 mice (online supplementary Table S1 ). Amplified products were inserted into the pGL3 vector (Promega), and reporter gene activity was assayed. HIF-2α binding sites (CGTG) in the Nampt promoter were mutated to AAAG using a site-directed mutagenesis kit (iNtRON Biotech), and the reporter gene activity of the mutant promoter was compared with that of the WT reporter gene. The HIF-2 reporter gene was constructed in a pGL3 vector by inserting four tandem repeats of 5´-GATCGCCCTACGTGCTGTCTCA-3´ into the upstream region of the SV40 promoter. Chondrocytes were transfected for 3 hours with HIF-2 reporter gene (1 µg) and a β-galactosidase expression vector (0.1 µg) using Lipofectamine 2000 (Invitrogen). Transfected cells were infected with Ad-Epas1 for 3 hours and treated with the indicated concentrations of FK866. Cells were harvested 36 hours after treatment, and luciferase activity was measured and expressed relative to β-galactosidase activity to normalize for transfection efficiency. ChIP assays of mouse articular chondrocytes treated with IL1β or infected with Ad-Epas1 at a MOI of 800 were performed using a kit (Millipore). The primers for the ChIP assay were designed to allow amplification of the three different HRE-containing regions of the Nampt promoter (online supplementary table S1). Cross-linking of DNA-proteins was induced by the addition of formaldehyde (1% final concentration) directly to the culture medium for 10 minutes at 37°C. Cells were lysed, and DNA in the supernatant was sheared by sonication. Sonicated chromatin was incubated overnight with 2 g of rabbit anti-mouse HIF-2 antibody (Novus Biologicals, NB100-122) or control anti-IgG antibody (Santa Cruz Biotechnology, SC-2027) at 4°C. Antibody-protein-DNA complexes were isolated with protein A-agarose. Eluted DNA was purified using phenol extraction and used as a template for PCR.
Skeletal staining
Skeletons of whole-mouse embryos were stained with alcian blue and alizarin red, as described previously.
7 Briefly, whole embryos were skinned, eviscerated, and fixed with 95% ethanol for 4 days and immersed in acetone for 3 days. Samples were stained in a freshly prepared staining solution composed of 1 volume of 0.3% alcian blue 8GX in 70% ethanol, 1 volume of 0.1% alizarin red S in 95% ethanol, 1 volume of 100% acetic acid, and 17 volumes of 100% ethanol. The samples were sequentially destained with 1% KOH for up to 48 hours and with 20% glycerol containing 1% KOH for 14 days. Images were acquired using a Zeiss SteREO Discovery V12 microscope.
MMP activity assays
Chondrocytes infected with Ad-Nampt for 2 hours were incubated in serum-free DMEM for an additional 36 hours. Conditioned medium was harvested and centrifuged for 3 minutes at 3000 rpm. MMP activity in collected supernatants was assayed using an EDANS/DabcylPlus fluorescence resonance energy transfer (FRET) peptide (SensoLyte 520 MMP assay kit; ANASPEC) according to the manufacturer's instructions. Briefly, supernatant was incubated with 1 mM 4-aminophenyl-mercuric acetate for 40 minutes at 37°C and then mixed with MMP substrate solution for 30 minutes at 37°C on a 96-well plate. The FRET substrate can be cleaved by MMP2, MMP3, MMP8, MMP9, MMP12, and MMP13. Upon cleavage into two separate fragments by MMP, the fluorescence of EDANS is restored and fluorescence intensity can be monitored. Fluorescence intensity was determined at excitation/emission wavelengths of 340 nm/520 nm using a fluorescence microplate reader. mRNAs were detected by RT-PCR (n  6). Values are presented as means ± SEM (*P < 0.01, **P < 0.001; NS, not significant). Chondrocytes were infected with Ad-C (800 MOI) or Ad-Nampt (at the indicated MOI) for 36 hours. IL6 mRNA levels and secreted IL6 protein (sIL6) were determined by RT-PCR and ELISA, respectively (n = 5). (C) Chondrocytes were treated with the indicated concentrations of recombinant IL6 protein for 24 hours, and NAMPT mRNA was quantified by qRT-PCR (n = 6) (left). Chondrocytes were treated with 100 ng/ml of IL6 for 24 hours, and expression levels (fold changes relative to vehicle controls) of the indicated genes were quantified by qRT-PCR (n = 10) (right). (D) Primary cultures of chondrocytes isolated from WT and Il6 -/-mice were infected with Ad-C (800 MOI) or Ad-Nampt (at the indicated MOI) for 36 hours. Expression of the indicated mRNAs was quantified by qRT-PCR (n = 5). Values are presented as means ± SEM (*P < 0.001, **P < 0.0001; NS, not significant). PFU) with or without FK866 (10 mg/kg). Synovitis was detected by safranin-O and hematoxylin staining (n = 10). Values are presented as means ± SEM (**P < 0.001). Scale bar: 100 m.
